Serum Procalcitonin in Patients with Acute Liver Failure.

Takaaki Sugihara, Masahiko Koda, Toshiaki Okamoto, Ken‐ichi Miyoshi, Tomomitsu Matono, Kenji Oyama, Keiko Hosho, Jun‐ichi Okano, Hajime Isomoto

PubMed · 2017 · 24 citations · 24 references

Full text

Open access

Concepts

Abstract

BACKGROUND: Procalcitonin (PCT) is a known diagnostic marker of bacterial infection. There are no previous reports of PCT concerning acute liver failure (ALF). We evaluated the clinical value of serum PCT levels in patients with ALF. METHODS: Forty-four patients with acute hepatitis (19 men and 25 women; median age, 40 years; range, 20-79 years) were retrospectively enrolled from January 2001 and June 2015. PCT levels were measured by saved serum samples obtained within 3 days after admission. ALF was defined as prothrombin time (PT) < 40% regardless of hepatic encephalopathy. RESULTS: = 0.0314), but it was not an independent prognostic factor. CONCLUSION: Serum PCT level was significantly higher in patients with ALF.

References

24